Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 DPSCs and SHEDs show MSC-like phenotypes and also possess the capacity to regenerate various somatic tissues including dental tissues.
Shinichiro Yoshida
 + 375 word(s) 375 2020-09-21 10:57:53 |
2 layout
Dean Liu
 Meta information modification 375 2020-10-13 05:59:52 | |
3 layout
Dean Liu
 -28 word(s) 347 2020-10-13 09:42:11 | |
4 layout
Dean Liu
 -28 word(s) 347 2020-10-13 09:43:14 | |
5 layout
Dean Liu
 -1 word(s) 346 2020-10-21 08:39:10 | |
6 format correct
Dean Liu
 Meta information modification 346 2020-10-21 09:03:06 | |
7 re-edit, layout
Dean Liu
 + 651 word(s) 997 2020-11-09 10:11:19 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Yoshida, S.; Tomokiyo, A.; Hasegawa, D.; Hamano, S.; Sugii, H.; Maeda, H. DPSCs in Regenerative Therapy. Encyclopedia. Available online: https://encyclopedia.pub/entry/2513 (accessed on 24 December 2024).
Yoshida S, Tomokiyo A, Hasegawa D, Hamano S, Sugii H, Maeda H. DPSCs in Regenerative Therapy. Encyclopedia. Available at: https://encyclopedia.pub/entry/2513. Accessed December 24, 2024.
Yoshida, Shinichiro, Atsushi Tomokiyo, Daigaku Hasegawa, Sayuri Hamano, Hideki Sugii, Hidefumi Maeda. "DPSCs in Regenerative Therapy" Encyclopedia, https://encyclopedia.pub/entry/2513 (accessed December 24, 2024).
Yoshida, S., Tomokiyo, A., Hasegawa, D., Hamano, S., Sugii, H., & Maeda, H. (2020, October 12). DPSCs in Regenerative Therapy. In Encyclopedia. https://encyclopedia.pub/entry/2513
Yoshida, Shinichiro, et al. "DPSCs in Regenerative Therapy." Encyclopedia. Web. 12 October, 2020.
DPSCs in Regenerative Therapy
Edit
This entry is adapted from the peer-reviewed paper 10.3390/biology9070160

Recently, dental pulp stem cells (DPSCs) and stem cells from human exfoliated deciduous teeth (SHEDs) have attracted substantial attention as promising cell sources for tissue regeneration. Here, we summarized the features of DPSCs and SHEDs such as high growth capacity, multipotency, expression of cell markers, immunomodulatory effects, and their potential to regenerate various somatic tissues. 

Mesenchymal stem cells (MSCs) have the capacity for self-renewal and multilineage differentiation potential, and are considered a promising cell population for cell-based therapy and tissue regeneration. MSCs are isolated from various organs including dental pulp, which originates from cranial neural crest-derived ectomesenchyme. Recently, dental pulp stem cells (DPSCs) and stem cells from human exfoliated deciduous teeth (SHEDs) have been isolated from dental pulp tissue of adult permanent teeth and deciduous teeth, respectively. Because of their MSC-like characteristics such as high growth capacity, multipotency, expression of MSC-related markers, and immunomodulatory effects, they are suggested to be an important cell source for tissue regeneration.

dental pulp stem cells stem cells from human exfoliated deciduous teeth regenerative therapy regenerative medicine

1. Introduction

Mesenchymal stem cells (MSCs) have been reported to be isolated from various somatic tissues such as bone marrow [1], adipose tissue stromal vascular fraction[2], umbilical cord [3], and placenta [4]. They are noteworthy for their robust self-renewal capacity and multilineage differentiation potential including osteogenic, adipogenic, chondrogenic, myogenic, neurogenic, and tenogenic[5][6][7][8]. Thus, cell-based medicine using MSCs is expected to facilitate tissue regeneration in various somatic disorders. MSC-like populations have also been identified in dental tissues. Gronthos et al. initially identified dental stem cells from the human pulp tissue and termed dental pulp stem cells (DPSCs)[9]. Subsequently, dental MSC-like populations from other dental tissues were identified and characterized: Stem cells from human exfoliated deciduous teeth (SHEDs)[10], periodontal ligament stem cells (PDLSCs)[11], dental follicle precursor cells (DFPCs)[12], and stem cells from apical papilla (SCAPs)[13]. Among these stem cells, DPSCs and SHEDs are more attractive as cell sources for regenerative medicine than other MSC-like populations because of their easy accessibility.

Dental pulp is an unmineralized connective tissue that is composed of stem cells as well as fibroblastic cells, capillary blood vessels, peripheral nerves, lymphatic elements, and extracellular matrices and odontoblasts on the periphery of pulp tissue. DPSCs are isolated from adult human pulp tissue of impacted third molars, orthodontic teeth, and supernumerary teeth, and have been characterized as cells with intense clonogenicity, proliferative activity, and the ability to form mineralized nodules[9] (Figure 1).

Biology 09 00160 g001

Figure 1. Isolation of dental pulp stem cells (DPSCs) and stem cells from human exfoliated deciduous teeth (SHEDs). DPSCs and SHEDs isolated from pulp tissue of permanent teeth and deciduous teeth, respectively, have the potential to be cell sources in regenerative medicine.

2. Self-Renewal and High Growth Capacity of DPSCs and SHEDs

The ability to self-renew is one of the essential defining features of stem cells. This ability is divided into two types according to how they self-renew. One involves generating daughter cells with developmental potential similar to that of the original stem cells (symmetric division), while the other involves generating both undifferentiated cells and cells fated to differentiate (asymmetric division)[14] (Figure 2). Consequently, stem cells can expand during development, be maintained in somatic tissues, and participate in tissue regeneration.

Biology 09 00160 g002Figure 2. Self-renewal mechanisms of stem cells. Stem cells are defined by their ability to make new stem cells (self-renewal). Self-renewal of stem cells is divided into two processes: Generation of daughter cells or of cells fated to differentiate.

3. Multipotency of DPSCs and SHEDs

DPSCs and SHEDs have the ability to differentiate into various cell types under appropriate culture conditions (Figure 3).

Biology 09 00160 g003Figure 3. Multipotency of DPSCs and SHEDs. DPSCs and SHEDs can differentiate into multiple lineages such as osteoblasts, odontoblasts, adipocytes, chondrocytes, neural cells, endotheliocytes, myocytes, hepatocytes, and pancreatic cells under appropriate culture conditions. In addition, DPSCs can also differentiate into corneal epithelial cells and cardiomyocytes.

4. Semaphorin 3A

Semaphorin 3A (Sema3A), which is a member of the semaphorin family, was identified as an axonal guidance factor regulating nervous system development[19], and has been reported to play important roles in the development of various tissues such as blood vessels, peripheral nerves, and skeletal tissues[20][21][22]. In addition, Sema3A acts as an osteoprotective factor by inhibiting osteoclastic bone resorption and promoting osteoblastic bone formation[24]. Our previous study demonstrated that a multipotent human PDL cell line[23] highly expressed Sema3A compared with a PDL cell line with low differentiation potential (low-potent)[25]. In addition, we generated a Sema3A-overexpressing low-potent PDL cell line and clarified that these cells exhibited enhanced capacity to differentiate into osteoblasts and adipocytes. Moreover, Sema3A-overexpression enhanced self-renewal ability and increased the expression levels of markers of pluripotency, such as Oct-4, Nanog, and E-cadherin, and; MSC-related markers, such as CD73, CD90, CD105, CD146, and CD166[26]. Our results indicate that Sema3A regulates the stem cell features of PDLSCs and induction of this gene provide multipotency for a low-potent PDL cell line. Yamada et al. reported that Sema3A knockdown decreased self-renewal ability and the expression of Sox2, Oct-4, and CD44 in lung cancer stem cells. Their results support our hypothesis that Sema3A would play an important role in acquisition and maintaining of stemness.

Recently, we demonstrated that Sema3A increased migration, proliferation, and odontoblastic differentiation of DPSCs (Figure 4). Moreover, Sema3A facilitated reparative dentin formation after direct pulp capping in a rat pulp exposure model. These results suggested that Sema3A can recruit latent DPSCs to the wounded site and increase its biological activities to regenerate dentin/pulp complex. At the present time, we are planning to clarify the precise mechanisms of epigenetic regulation by Sema3A and to confirm the possibility for its use as a therapeutic agent that could increase the activity of hosts’ latent progenitor cells, especially DPSCs.

Biology 09 00160 g004Figure 4. Schema of the effects of Semaphorin 3A (Sema3A) on DPSCs. In case of pulp exposure, DPSCs migrate toward the exposure site, then they proliferate and differentiate into odontoblasts to form reparative dentin. Sema3A can act as a bioactive agent to facilitate these regenerative processes. #, sealing material; *, Sema3A.

References

  1. Haynesworth, S.E.; Goshima, J.; Goldberg, V.M.; Caplan, A.I. Characterization of cells with osteogenic potential from human marrow. Bone 1992, 13, 81–88.
  2. Halvorsen, Y.C.; Wilkison, W.O.; Gimble, J.M. Adipose-derived stromal cells--their utility and potential in bone formation. Int. J. Obes. Relat. Metab. Disord. J. Int. Assoc. Study Obes. 2000, 24 (Suppl. 4), S41–S44.
  3. Erices, A.; Conget, P.; Minguell, J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 2000, 109, 235–242.
  4. In’t Anker, P.S.; Scherjon, S.A.; Kleijburg-van der Keur, C.; de Groot-Swings, G.M.; Claas, F.H.; Fibbe, W.E.; Kanhai, H.H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells (Dayt. Ohio) 2004, 22, 1338–1345.
  5. Pittenger, M.F.; Mackay, A.M.; Beck, S.C.; Jaiswal, R.K.; Douglas, R.; Mosca, J.D.; Moorman, M.A.; Simonetti, D.W.; Craig, S.; Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284, 143–147.
  6. Makino, S.; Fukuda, K.; Miyoshi, S.; Konishi, F.; Kodama, H.; Pan, J.; Sano, M.; Takahashi, T.; Hori, S.; Abe, H.; et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Investig. 1999, 103, 697–705.
  7. Sanchez-Ramos, J.; Song, S.; Cardozo-Pelaez, F.; Hazzi, C.; Stedeford, T.; Willing, A.; Freeman, T.B.; Saporta, S.; Janssen, W.; Patel, N.; et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. 2000, 164, 247–256.
  8. Caplan, A.I. Mesenchymal stem cells. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 1991, 9, 641–650.
  9. Gronthos, S.; Mankani, M.; Brahim, J.; Robey, P.G.; Shi, S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2000, 97, 13625–13630.
  10. Miura, M.; Gronthos, S.; Zhao, M.; Lu, B.; Fisher, L.W.; Robey, P.G.; Shi, S. SHED: Stem cells from human exfoliated deciduous teeth. Proc. Natl. Acad. Sci. USA 2003, 100, 5807–5812.
  11. Seo, B.M.; Miura, M.; Gronthos, S.; Bartold, P.M.; Batouli, S.; Brahim, J.; Young, M.; Robey, P.G.; Wang, C.Y.; Shi, S. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet (Lond. Engl.) 2004, 364, 149–155.
  12. Morsczeck, C.; Schmalz, G.; Reichert, T.E.; Völlner, F.; Galler, K.; Driemel, O. Somatic stem cells for regenerative dentistry. Clin. Oral Investig. 2008, 12, 113–118.
  13. Sonoyama, W.; Liu, Y.; Fang, D.; Yamaza, T.; Seo, B.M.; Zhang, C.; Liu, H.; Gronthos, S.; Wang, C.Y.; Wang, S.; et al. Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS ONE 2006, 1, e79.
  14. Sanchez-Taltavull, D. Optimal architecture of differentiation cascades with asymmetric and symmetric stem cell division. J. Theor. Biol. 2016, 407, 106–117.
  15. Wright, D.E.; White, F.A.; Gerfen, R.W.; Silos-Santiago, I.; Snider, W.D. The guidance molecule semaphorin III is expressed in regions of spinal cord and periphery avoided by growing sensory axons. J. Comp. Neurol. 1995, 361, 321–333.
  16. Bates, D.; Taylor, G.I.; Minichiello, J.; Farlie, P.; Cichowitz, A.; Watson, N.; Klagsbrun, M.; Mamluk, R.; Newgreen, D.F. Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1. Dev. Biol. 2003, 255, 77–98.
  17. Eichmann, A.; Le Noble, F.; Autiero, M.; Carmeliet, P. Guidance of vascular and neural network formation. Curr. Opin. Neurobiol. 2005, 15, 108–115.
  18. Gomez, C.; Burt-Pichat, B.; Mallein-Gerin, F.; Merle, B.; Delmas, P.D.; Skerry, T.M.; Vico, L.; Malaval, L.; Chenu, C. Expression of Semaphorin-3A and its receptors in endochondral ossification: Potential role in skeletal development and innervation. Dev. Dyn. Off. Publ. Am. Assoc. Anat. 2005, 234, 393–403.
  19. Hayashi, M.; Nakashima, T.; Taniguchi, M.; Kodama, T.; Kumanogoh, A.; Takayanagi, H. Osteoprotection by semaphorin 3A. Nature 2012, 485, 69–74.
  20. Tomokiyo, A.; Maeda, H.; Fujii, S.; Wada, N.; Shima, K.; Akamine, A. Development of a multipotent clonal human periodontal ligament cell line. Differ. Res. Biol. Divers. 2008, 76, 337–347.
  21. Wada, N.; Maeda, H.; Hasegawa, D.; Gronthos, S.; Bartold, P.M.; Menicanin, D.; Fujii, S.; Yoshida, S.; Tomokiyo, A.; Monnouchi, S.; et al. Semaphorin 3A induces mesenchymal-stem-like properties in human periodontal ligament cells. Stem Cells Dev. 2014, 23, 2225–2236.
  22. Yamada, D.; Takahashi, K.; Kawahara, K.; Maeda, T. Autocrine Semaphorin3A signaling is essential for the maintenance of stem-like cells in lung cancer. Biochem. Biophys. Res. Commun. 2016, 480, 375–379.
  23. Hayashi, M.; Nakashima, T.; Taniguchi, M.; Kodama, T.; Kumanogoh, A.; Takayanagi, H. Osteoprotection by semaphorin 3A. Nature 2012, 485, 69–74.
  24. Tomokiyo, A.; Maeda, H.; Fujii, S.; Wada, N.; Shima, K.; Akamine, A. Development of a multipotent clonal human periodontal ligament cell line. Differ. Res. Biol. Divers. 2008, 76, 337–347.
  25. Wada, N.; Maeda, H.; Hasegawa, D.; Gronthos, S.; Bartold, P.M.; Menicanin, D.; Fujii, S.; Yoshida, S.; Tomokiyo, A.; Monnouchi, S.; et al. Semaphorin 3A induces mesenchymal-stem-like properties in human periodontal ligament cells. Stem Cells Dev. 2014, 23, 2225–2236.
  26. Yamada, D.; Takahashi, K.; Kawahara, K.; Maeda, T. Autocrine Semaphorin3A signaling is essential for the maintenance of stem-like cells in lung cancer. Biochem. Biophys. Res. Commun. 2016, 480, 375–379.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Biochemistry & Molecular Biology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Shinichiro Yoshida
,
Atsushi Tomokiyo
,
Daigaku Hasegawa
,
Sayuri Hamano
,
Hideki Sugii
,
Hidefumi Maeda
View Times: 1.4K
Revisions: 7 times (View History)
Update Date: 09 Nov 2020
Table of Contents
    1000/1000
    Hot Most Recent
    Video Production Service
    Feedback